Safety and Immunogenicity Study of SCB-1019T in Children (clinicaltrials.gov) - Oct 30, 2024 - P1 | N=112 | Not yet recruiting | Sponsor: Clover Biopharmaceuticals AUS Pty Ltd
New P1 trial • Infectious Disease • Respiratory Diseases • Respiratory Syncytial Virus Infections
|